Correlation Engine 2.0
Clear Search sequence regions


  • amphotericin b (10)
  • female (1)
  • humans (1)
  • hypophosphatemia (4)
  • patients (3)
  • phosphate (6)
  • phosphorus (1)
  • plasma (2)
  • vitro (4)
  • Sizes of these terms reflect their relevance to your search.

    Hypophosphatemia is commonly observed in critically ill patients. Inorganic phosphorus is quantified by spectrophotometric measurement of a phosphomolybdate complex, a method with multiple documented interferents. Our clinical laboratory was contacted to investigate a case of asymptomatic hypophosphatemia in a patient receiving high-dose liposomal amphotericin B therapy (L-AMB). In vitro experiments were performed by spiking L-AMB into residual plasma specimens. Phosphate was measured on the Beckman Coulter AU and Ortho Diagnostics Vitros instruments. When measured on the AU, phosphate in plasma with approximately 250mcg/mL of L-AMB demonstrated a median negative bias of 3.45mg/dL relative to unspiked samples. In contrast, Vitros phosphate measurements demonstrated excellent agreement for specimens with and without L-AMB (median bias -0.2mg/dL). High L-AMB concentrations induced a significant negative bias on phosphate measured by the AU assay, but did not affect the Vitros assay. Laboratorians and clinicians should be aware of this phenomenon in patients receiving L-AMB who develop unexplained hypophosphatemia. Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

    Citation

    James A Mays, Dina N Greene, Anne Poon, Anna E Merrill. Pseudohypophosphatemia associated with high-dose liposomal amphotericin B therapy. Clinical biochemistry. 2017 Nov;50(16-17):967-971

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28578095

    View Full Text